Phibro Animal Health (PAHC) Return on Capital Employed Growth (1y) (2015 - 2026)
Phibro Animal Health (PAHC) Return on Capital Employed Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 1,195.00 |
| 10 | Phibro Animal Health | 1.42 Bn | 1.34 Bn | 125.68 Mn | 654.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 654.00 |
| Dec 31, 2025 | 603.00 |
| Sep 30, 2025 | 406.00 |
| Jun 30, 2025 | 370.00 |
| Mar 31, 2025 | 174.00 |
| Dec 31, 2024 | 180.00 |
| Sep 30, 2024 | 178.00 |
| Jun 30, 2024 | -220.00 |
| Mar 31, 2024 | -143.00 |
| Dec 31, 2023 | -176.00 |
| Sep 30, 2023 | -295.00 |
| Jun 30, 2023 | -171.00 |
| Mar 31, 2023 | -193.00 |
| Dec 31, 2022 | -218.00 |
| Sep 30, 2022 | -59.00 |
| Jun 30, 2022 | -59.00 |
| Mar 31, 2022 | -80.00 |
| Dec 31, 2021 | -64.00 |
| Sep 30, 2021 | -119.00 |
| Jun 30, 2021 | 25.00 |